|
|
Manuel Yepes, Maria Sandkvist, Timothy A. Coleman, Elizabeth Moore, Jiang-Young Wu, David Mitola, Thomas H. Bugge, Daniel A. Lawrence
J Clin Invest. 2002;
109(12):1571
doi:10.1172/JCI14308
Abstract |
Full text
| PDF

T
issue-type plasminogen activator (tPA) is a highly specific serine proteinase expressed in the CNS during events that require neuronal plasticity. In this study we demonstrate that endogenous tPA mediates the progression of kainic acid–induced (KA-induced) seizures by promoting the synchronization of neuronal activity required for seizure spreading, and that, unlike KA-induced cell death, this activity is plasminogen-independent. Specifically, seizure induction by KA injection into the amygdala induces tPA activity and cell death in both hippocampi, and unilateral treatment of rats with neuroserpin, a natural inhibitor of tPA in the brain, enhances neuronal survival in both hippocampi. Inhibition of tPA within the hippocampus by neuroserpin treatment does not prevent seizure onset but instead markedly delays the progression of seizure activity in both rats and wild-type mice. In tPA-deficient mice, seizure progression is significantly delayed, and neuroserpin treatment does not further delay seizure spreading. In contrast, plasminogen-deficient mice show a pattern of seizure spreading and a response to neuroserpin that is similar to that of wild-type animals. These findings indicate that tPA acts on a substrate other than plasminogen and that the effects of neuroserpin on seizure progression and neuronal cell survival are mediated through the inhibition of tPA.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation
Maithili Sashindranath, Andre Laval Samson, Catherine Eliza Downes, Peter John Crack, Andrew John Lawrence, Qiao-Xin Li, Ashley Quan Ping Ng, Nigel Charles Jones, Jessica Jade Farrugia, Eman Abdella, Jean-Dominique Vassalli, Rime Madani, Robert Lindsay Medcalf
|
Lab Invest
|
2011 |
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
A. Machado, A. J. Herrera, J. L. Venero, M. Santiago, R. M. de Pablos, R. F. Villarán, A. M. Espinosa-Oliva, S. Argüelles, M. Sarmiento, M. J. Delgado-Cortés, R. Mauriño, J. Cano
|
ISRN Neurology
|
2011 |
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity
George W J Harston, Brad A Sutherland, James Kennedy, Alastair M Buchan
|
J Cereb Blood Flow Metab
|
2010 |
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.
Jie An, Chen Zhang, Rohini Polavarapu, Xiaohui Zhang, Xiumei Zhang, Manuel Yepes
|
Blood
|
2008 |
Dynamic Changes of Proteases and Protease Inhibitors Revealed by Microarray Analysis in CA3 and Entorhinal Cortex during Epileptogenesis in the Rat
Jan A. Gorter, Erwin A. Van Vliet, Han Rauwerda, Timo Breit, Robert Stad, Linda van Schaik, Erno Vreugdenhil, Sandra Redeker, Erik Hendriksen, Eleonora Aronica, Fernando H. Lopes da Silva, Wytse J. Wadman
|
Epilepsia
|
2007 |
Tissue Plasminogen Activator, Neuroserpin, and Seizures
Annamaria Vezzani
|
Epilepsy Currents
|
2005 |
Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability
A. P. LILLIS, I. MIKHAILENKO, D. K. STRICKLAND
|
Journal of Thrombosis and Haemostasis
|
2005 |
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.
Manel G Medina, Maria Dolores Ledesma, Jorge E Domínguez, Miguel Medina, Delia Zafra, Francesc Alameda, Carlos G Dotti, Pilar Navarro
|
EMBO J
|
2005 |
The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?
Nathalie Lebeurrier, Denis Vivien, Carine Ali
|
Expert Opin. Ther. Targets
|
2004 |
Tissue plasminogen activator is a potent activator of PDGF-CC.
Linda Fredriksson, Hong Li, Christina Fieber, Xuri Li, Ulf Eriksson
|
EMBO J
|
2004 |
|